Therapie der Hypertonie im Alter

Literatur

• 1 Appel L J, Espeland M A, Easter L. et al . Effects of reduced sodium intake on hypertension control in older individuals: Results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE).  Arch Intern Med. 2001;  161 685-693
  Google Scholar
• 2 Burt V L, Whelton P, Roccella E J. et al . Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988 - 1991.  Hypertension. 1995;  25 305-313
  Google Scholar
• 3 Chobanian A V, Bakris G L, Black H R. et al . Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  Hypertension. 2003;  42 1206-1252
  Google Scholar
• 4 Gueyffier F, Bulpitt C, Boissel J P. et al . Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials.  Lancet. 1999;  353 793-796
  Google Scholar
• 5 Holzgreve H. Der Nutzen der antihypertensiven Therapie. Wie viel Schaden verhindert sie wirklich?.  MMW-Fortschr Med. 2006;  148 47-50
  Google Scholar
• 6 Holzgreve H, Middeke M. Treatment of hypertension in the elderly.  Drugs. 1993;  46 (suppl 2) 24-31
  Google Scholar
• 7 Kannel W B. Blood pressure as a cardiovascular risk factor.  JAMA. 1996;  275 1571-1576
  Google Scholar
• 8 Lindholm L H, Carlberg B, Samuelsson O. Should beta-blockers remain first choice in the treatment of primary hypertension? A meta analysis.  Lancet. 2005;  366 1545-1553
  Google Scholar
• 9 Lloyd-Jones D M, Evans J C, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community.  JAMA. 2005;  294 466-472
  Google Scholar
• 10 Lüders S, Franz I W, Hilgers K F. et al . Langzeitblutdruckmessung - Statement der Deutschen Hochdruckliga e. V. DHL (Deutsche Hypertonie Gesellschaft), Sektion Hochdruck-Diagnostik.  Dtsch Med Wochenschr. 2005;  130 2664-2668
  Google Scholar
• 11 Messerli F H, Grossman E, Goldbourt U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.  JAMA. 1998;  279 1903-1907
  Google Scholar
• 12 Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of the prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists`Collaboration.  Lancet. 2000;  356 1955-1964
  Google Scholar
• 13 Schulman S P, Weiss J L, Becker L C. et al . The effects of antihypertensive therapy on left ventricular mass in elderly patients.  N Eng J Med. 1990;  322 1350-1356
  Google Scholar
• 14 Somes G W, Pahor M, Shorr R I. et al . The role of diastolic blood pressure when treating isolated systolic hypertension.  Arch Intern Med. 1999;  159 2004-2009
  Google Scholar
• 15 Staessen J A, Gasowski J, Wang J G. et al . Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials.  Lancet. 2000;  355 865-872
  Google Scholar
• 16 Trenkwalder P, Ruland D, Stender M. et al . Prevalence, awareness, treatment and control of hypertension in a population over the age of 65.  J Hypertens. 1994;  12 709-716
  Google Scholar
• 17 Van der Giet M. Isolierte systolische Hypertonie.  Dtsch Med Wochenschr. 2005;  130 2653-2656
  Google Scholar

Prof. Dr. med. Peter Trenkwalder

Klinikum Starnberg, Akad. Lehrkrankenhaus der Ludwig-Maximilians-Universität München

Osswaldstraße 1

82319 Starnberg

Phone: 08151/182240

Fax: 08151/182243

Email: Peter.Trenkwalder@klinikum-starnberg.de